Velovia Pharma, LLC Exercises Option for One Licensed Compound for Veterinary Use and RaQualia Pharma Receives Upfront Payment
  • May 20, 2026
サブ-ナビゲーション
  • PICK UP
  • News
    • Notices
    • 現在位置:IR News
  • Corporate Information
  • Research & Development
  • Pipeline
  • Products
  • IR Information
  • Contact Us
  • Privacy Policy
  • Site Policy

Velovia Pharma, LLC Exercises Option for One Licensed Compound for Veterinary Use and RaQualia Pharma Receives Upfront Payment

  • May 20, 2026

  • CLOSE
  • MENU

サイト内検索

Cookie Policy

We use cookies to provide you with a better browsing experience.
Please confirm that you agree to our use of cookies by clicking Yes.
If you continue to browse this website even without agreeing to our use of cookies,
we consider that you have consented to our use of cookies.

Privacy Policy

Yes

  • footer-content
  • header-content
  • header-content